Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 40.0 | 26.5 | 11.2 | 0.0 | 0.0 | 0.4 | 30.0 | 1.0 |
Revenue growth | 50.7% | 136.2% | | | -100.0% | -98.6% | 2928.4% | -55.9% |
Cost of goods sold | -117.9 | -91.9 | -43.5 | 0.0 | 0.0 | 0.0 | -28.2 | 0.0 |
Gross profit | 157.9 | 118.5 | 54.7 | 0.0 | 0.0 | 0.4 | 58.2 | 1.0 |
Gross margin | 394.8% | 446.3% | 487.1% | | | 100.0% | 194.1% | 100.0% |
Research and development | 38.6 | 25.3 | 29.2 | 24.7 | 14.1 | 12.5 | 13.5 | 26.3 |
General and administrative | 39.8 | 29.4 | 14.3 | 12.2 | 11.6 | 8.1 | 14.7 | 9.9 |
EBIT | -38.4 | -28.2 | -32.3 | -36.9 | -25.7 | -20.2 | 2.9 | -35.2 |
EBIT margin | -96.0% | -106.1% | -287.1% | | | -4742.4% | 9.6% | -3555.2% |
Pre-tax income | -23.8 | -8.6 | -21.0 | -107.5 | -33.7 | -29.0 | 1.9 | -33.5 |
Income taxes | 3.9 | 8.3 | -1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | 6.9% | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% |
Net income | -19.9 | -0.3 | -22.5 | -107.5 | -33.7 | -29.0 | 1.9 | -33.5 |
Net margin | -49.7% | -1.3% | -200.6% | | | -6830.4% | 6.3% | -3379.0% |
|
Diluted EPS | ($0.10) | $0.00 | ($0.19) | ($1.18) | ($0.55) | ($1.11) | $0.09 | ($1.76) |
Shares outstanding (diluted) | 200.5 | 182.3 | 118.2 | 90.9 | 61.8 | 26.1 | 21.7 | 19.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|